Detailed answers about GYNAE-ONCOLOGY RESEARCH AND CLINICAL EXCELLENCE ("GRACE"), including incorporation, status, business activity, and accounts information.
When was GYNAE-ONCOLOGY RESEARCH AND CLINICAL EXCELLENCE ("GRACE") founded?
GYNAE-ONCOLOGY RESEARCH AND CLINICAL EXCELLENCE ("GRACE") was officially incorporated on 1 June 2020 and is registered under company number CE022016. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is GYNAE-ONCOLOGY RESEARCH AND CLINICAL EXCELLENCE ("GRACE")?
Charitable Incorporated Organisation. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations.
What is the current status of GYNAE-ONCOLOGY RESEARCH AND CLINICAL EXCELLENCE ("GRACE")?
GYNAE-ONCOLOGY RESEARCH AND CLINICAL EXCELLENCE ("GRACE")'s current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What is GYNAE-ONCOLOGY RESEARCH AND CLINICAL EXCELLENCE ("GRACE")'s registered address?
The registered office address of GYNAE-ONCOLOGY RESEARCH AND CLINICAL EXCELLENCE ("GRACE") is . This is the official address filed with Companies House for legal and statutory correspondence.
Is GYNAE-ONCOLOGY RESEARCH AND CLINICAL EXCELLENCE ("GRACE") financially stable?
Financial accounts for GYNAE-ONCOLOGY RESEARCH AND CLINICAL EXCELLENCE ("GRACE") are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.